Abstract: The present invention provides a device for treating dementia, including: a plurality of ultrasound probes; an ultrasound transducer arranged in each of the ultrasound probes and configured to propagate unfocused ultrasound energy to a brain; and an ultrasound generator connected to each of the ultrasound probes.

Abstract: The present invention provides a device for treating dementia, including: a plurality of ultrasound probes; an ultrasound transducer arranged in each of the ultrasound probes and configured to propagate unfocused ultrasound energy to a brain; and an ultrasound generator connected to each of the ultrasound probes.

Abstract: The present invention provides a preventive or therapeutic agent for pulmonary hypertension, including a compound represented by the following formula (I) or a salt thereof: where: —A— represents —NH—, —S—, or —O—; R1 and R2 are identical to or different from each other, and each represent a hydrogen atom or an alkyl group; R3 represents a hydrogen atom, a halogen atom, or an alkyl group; R4 represents a hydrogen atom or an alkyl group; R5 represents a hydrogen atom or an alkyl group; R6 and R7 are identical to or different each other, and each represent a hydrogen atom, a halogen atom, or an alkyl group; and R6 and R7 may form an unsaturated hydrocarbon six-membered ring together with a carbon atom to which R6 is bonded and a carbon atom to which R7 is bonded.

Abstract: An object to be achieved by the present invention is to provide a novel preventive or therapeutic agent for pulmonary hypertension containing as an active ingredient a compound that has not been known for a therapeutic effect on pulmonary hypertension heretofore. The present invention provides a preventive or therapeutic agent for pulmonary hypertension, including at least one kind selected from the group consisting of mebendazole and itraconazole or a salt thereof.

Abstract: A shock wave generating device includes an optical fiber and a reflective part, and is configured to reflect and converge the shock wave generated inside the reflective part to an outside of the reflective part. The reflective part includes: a reflector having a concave surface having a cut surface-of-revolution shape, and a through hole, which is formed coaxially with a rotating axis of the concave surface, and into which the optical fiber is to be inserted; a sealing body configured to seal an opening portion of the concave surface; and a liquid to be charged between the concave surface and the sealing body. The optical fiber has a distal end arranged at a position on a rear side of a focal point of the concave surface, at which the shock wave reflected by the concave surface is convergeable outside the reflective part.

Abstract: A primary object of the present invention is to provide a method for conveniently and accurately testing for pulmonary hypertension. To achieve this object, the present invention provides a method for testing for pulmonary hypertension using as an indicator the concentration of selenoprotein P protein in a sample derived from a subject.

Abstract: A problem to be solved by the present invention is to provide a novel preventive or therapeutic agent for pulmonary hypertension containing as an active ingredient a compound that has not been known for a therapeutic effect on pulmonary hypertension heretofore. The present invention provides a preventive or therapeutic agent for pulmonary hypertension containing a PPAR? agonist.

Abstract: A problem to be solved by the present invention is to provide a novel preventive or therapeutic agent for pulmonary hypertension containing as an active ingredient a compound that has not been known for a therapeutic effect on pulmonary hypertension heretofore. The present invention provides a preventive or therapeutic agent for pulmonary hypertension containing celastrol or a salt thereof.

Abstract: The present invention provides a preventive or therapeutic agent for pulmonary hypertension, including a compound represented by the following formula (I) or a salt thereof: where: -A- represents —NH—, —S—, or —O—; R1 and R2 are identical to or different from each other, and each represent a hydrogen atom or an alkyl group; R3 represents a hydrogen atom, a halogen atom, or an alkyl group; R4 represents a hydrogen atom or an alkyl group; R5 represents a hydrogen atom or an alkyl group; R6 and R7 are identical to or different each other, and each represent a hydrogen atom, a halogen atom, or an alkyl group; and R6 and R7 may form an unsaturated hydrocarbon six-membered ring together with a carbon atom to which R6 is bonded and a carbon atom to which R7 is bonded.

Abstract: A probe (10) transmits and receives diagnostic ultrasound and therapeutic ultrasound. A transmission unit (12) forms a transmission beam of the therapeutic ultrasound having a higher wave number than the diagnostic ultrasound and scans the transmission beam of the therapeutic ultrasound in a therapeutic region set inside a diagnostic region by controlling the probe (10). Since the therapeutic ultrasound having a higher wave number than the diagnostic ultrasound is used, the therapeutic effect is higher than when using a therapeutic ultrasound having a similar wave number to the diagnostic ultrasound, and since the transmission beam of the therapeutic ultrasound is scanned in the therapeutic region, the therapeutic effect is higher than when the transmission beam of the therapeutic ultrasound is not scanned.

Abstract: An object to be achieved by the present invention is to provide a novel preventive or therapeutic agent for pulmonary hypertension containing as an active ingredient a compound that has not been known for a therapeutic effect on pulmonary hypertension heretofore. The present invention provides a preventive or therapeutic agent for pulmonary hypertension, including at least one kind selected from the group consisting of mebendazole and itraconazole or a salt thereof.

Abstract: This heart failure degree-of-exacerbation determination system comprises a storage device (11) and an arithmetic device (12). The arithmetic device (12) includes a heart failure degree-of-exacerbation determination means (121) for determining the degree-of-exacerbation of heart failure, on the basis of stored information which is stored in the storage device (11) and the correlation among a plurality of evaluation values which are associated with a acral portion of a patient.

Abstract: A shock wave generating device includes an optical fiber and a reflective part, and is configured to reflect and converge the shock wave generated inside the reflective part to an outside of the reflective part. The reflective part includes: a reflector having a concave surface having a cut surface-of-revolution shape, and a through hole, which is formed coaxially with a rotating axis of the concave surface, and into which the optical fiber is to be inserted; a sealing body configured to seal an opening portion of the concave surface; and a liquid to be charged between the concave surface and the sealing body. The optical fiber has a distal end arranged at a position on a rear side of a focal point of the concave surface, at which the shock wave reflected by the concave surface is convergeable outside the reflective part.

Abstract: The present invention provides a device for treating dementia, including: a plurality of ultrasound probes; an ultrasound transducer arranged in each of the ultrasound probes and configured to propagate unfocused ultrasound energy to a brain; and an ultrasound generator connected to each of the ultrasound probes.

Abstract: A problem to be solved by the present invention is to provide a novel preventive or therapeutic agent for pulmonary hypertension containing as an active ingredient a compound that has not been known for a therapeutic effect on pulmonary hypertension heretofore. The present invention provides a preventive or therapeutic agent for pulmonary hypertension containing emetine or a salt thereof.

Abstract: Methods of further reducing cardiovascular risk in subjects with coronary artery disease on moderate intensity statins.

Abstract: A problem to be solved by the present invention is to provide a novel preventive or therapeutic agent for pulmonary hypertension containing as an active ingredient a compound that has not been known for a therapeutic effect on pulmonary hypertension heretofore. The present invention provides a preventive or therapeutic agent for pulmonary hypertension containing an ingredient having a selenoprotein P activity-inhibiting action.

Abstract: A problem to be solved by the present invention is to provide a novel preventive or therapeutic agent for pulmonary hypertension containing as an active ingredient a compound that has not been known for a therapeutic effect on pulmonary hypertension heretofore. The present invention provides a preventive or therapeutic agent for pulmonary hypertension containing emetine or a salt thereof.

Abstract: When a user designates a treatment range on a diagnostic image, a switch (12) selects a transmitter for treatment (16). Ultrasound with intensity for treatment is thereby transmitted from a probe (10) to the inside of an organism. When the treatment operation continues for a prescribed time, a control unit (18) controls the switch (12) to select a transmitter for diagnosis (14). The probe (10) thereby emits an ultrasound beam for diagnosis, senses an echo thereof, generates a diagnostic image, and carries out an inspection of a positional shift of the site to be treated. In the inspection, the control unit (18) compares the diagnostic image with a reference image, and if a significant difference is detected therebetween, determines that a shift has occurred, issues an alarm, and urges the user to correct the positional shift. It is possible to resume the treatment when the positional shift has been corrected.

Abstract: A problem to be solved by the present invention is to provide a novel preventive or therapeutic agent for pulmonary hypertension containing as an active ingredient a compound that has not been known for a therapeutic effect on pulmonary hypertension heretofore. The present invention provides a preventive or therapeutic agent for pulmonary hypertension containing celastrol or a salt thereof.